ATXS(Delisted)
Astria Therapeutics·NASDAQ
--
--(--)
ATXS fundamentals
Astria Therapeutics (ATXS) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.57 (YoY -32.56%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.57
-32.56%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 12, 2025
Meeting link.EPS
Actual | -3 | -3.18 | -3.36 | -2.7 | -45.6 | -5.34 | -0.61 | -0.73 | -1.18 | -0.86 | -0.87 | -0.72 | -0.4 | -0.45 | -0.63 | -0.86 | -0.38 | -0.43 | -0.42 | -0.44 | -0.58 | -0.57 | |||||||||||
Forecast | -2.46 | -2.73 | -3.06 | -2.04 | -0.54 | -1.2 | -0.878 | -0.61 | -0.728 | -0.9275 | -0.85 | -0.6883 | -0.5517 | -0.4717 | -0.4867 | -0.78 | -0.34 | -0.3683 | -0.4217 | -0.4517 | -0.4783 | -0.5884 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -21.95% | -16.48% | -9.80% | -32.35% | -8344.44% | -345.00% | +30.52% | -19.67% | -62.09% | +7.28% | -2.35% | -4.61% | +27.50% | +4.60% | -29.44% | -10.26% | -11.76% | -16.75% | +0.40% | +2.59% | -21.26% | +3.13% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
No Data
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
